NCT00243152View on ClinicalTrials.gov

Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI

NACompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Facial Neuropathy

Interventions

DRUG

Lamotrigine

: 25mg and 50mg tablets

DRUG

Placebo (for Lamotrigine)

Sugar pill manufactured to mimic Lamotrigine tablets

Trial Locations (1)

02478

McLean Hospital Neuroimaging Center, 115 Mill Street, Belmont

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Pain and Analgesia Imaging and Neuroscience Group

OTHER